Voltran Système de photothérapie pour la rhinite allergique

Voltran Système de photothérapie pour la rhinite allergique

Un appareil de photothérapie avancé conçu pour soulager les symptômes de la rhinite allergique en délivrant une luminothérapie ciblée, en réduisant l'inflammation et en améliorant le flux d'air nasal sans nécessiter de médicaments.

Informations

Voltran Phototherapy System is an innovative soft laser therapy device specially developed for intranasal phototherapy, providing an effective and noninvasive solution for seasonal and perennial allergic rhinitis. Operating at 630 nm wavelength, Voltran targets the nasal mucosa to alleviate common symptoms of allergic reactions—such as sneezing, nasal congestion, itching, and watery eyes—while reducing reliance on long-term medications or invasive treatments.

Technology and Mechanism of Action

630 nm Soft Laser
  • Specific Wavelength: Focuses on the nasal mucosa, facilitating localized photo-biomodulation and diminishing allergic responses.
  • Painless Application: Generates no heat sensation or tissue damage, ensuring a comfortable patient experience during each 5-minute session.
  • Histamine Release Prevention: Soft laser influences immune cells (mast cells, T lymphocytes, and eosinophils) to reduce histamine production and release, limiting allergic inflammation.
  • Immunological Effects: Decreases the levels of eosinophils, ECP, Interleukin-5, and other mediators in nasal secretions—improving nasal symptoms and overall quality of life.
  • Intranasal Probes: Engineered for quick, accurate positioning within the nostrils, distributing coherent light directly to the nasal mucosa.
  • User-Friendly Interface: Guides practitioners or patients through simplified steps, ensuring straightforward operation while maintaining patient safety.

Avantages cliniques

Effective for Seasonal & Perennial Allergic Rhinitis
  • Rapid Symptom Relief: Many patients observe improvement in sneezing, nasal discharge, itching, and congestion after only a few sessions.
  • Year-Round Benefit: Controls symptoms triggered by pollen, dust mites, mold, or other perennial allergens.
  • Reduced Medication Dependency: Ideal for individuals who cannot tolerate standard allergy medications or experience side effects and wish to minimize long-term drug use.
  • Outpatient Use: Sessions are typically 5 minutes in duration, allowing convenient scheduling without extended hospital stays.
  • No Thermal Damage: Despite its laser-based origin, the 630 nm soft laser does not heat tissues or induce pain.
  • No Bleeding or Tissue Trauma: The device neither physically disrupts mucosal surfaces nor requires incisions.
  • No Permanent Tissue Damage: Soft laser therapy exerts no harmful cumulative impact on nasal mucosa, suitable for repeated use in chronic allergic rhinitis management.
  • Immunomodulatory Effects: Photo-biomodulation can help stabilize nasal immune response over multiple treatments.

Patient Selection & Considerations

Candidats idéaux
  • Refractory Allergic Rhinitis: Patients not adequately controlled by nasal sprays or oral antihistamines.
  • Contraindications with Standard Therapies: Those experiencing medication side effects or interactions.
  • Preference for Nonpharmacological Options: Individuals seeking minimal medication usage.
  • Severe Structural Nasal Obstructions: Deviated septum or significant anatomical anomaly preventing device probe placement.
  • Acute Viral/Bacterial Infections: Infections requiring standard treatments prior to phototherapy consideration.
  • Tumors or Significant Nasopharyngeal Abnormalities: Risk of overshadowing or misinterpretation of therapy results.
  • Severe Nasal Dryness or Crusting: Could complicate device insertion or hamper therapy comfort.
  • Pacemakers or Cochlear Implants: In certain cases, electromagnetic considerations may preclude laser usage (verify local guidelines).

Produits apparentés